E75.26 Sulfatase deficiency

Name of the Condition

• Sulfatase deficiency (ICD-10 Code: E75.26)

Summary

Sulfatase deficiency is a rare inherited lysosomal storage disorder characterized by the abnormal accumulation of sulfatides or related compounds in cells due to impaired sulfatase enzyme activity. This buildup disrupts cellular function, particularly affecting the nervous system, and is part of a broader group of sphingolipid metabolism disorders. The condition presents with progressive neurological decline, though specific manifestations vary depending on the subtype.

Causes

These disorders result from genetic mutations that impair the activity of sulfatase enzymes, which are critical for breaking down sulfatides. The mutations lead to the buildup of specific sulfatides in tissues. Inheritance is typically autosomal recessive, meaning both copies of the gene must be mutated for the condition to manifest.

Risk Factors

• Family history of sulfatase deficiency or related lysosomal storage disorders.
• Consanguineous relationships, increasing the likelihood of recessive gene mutations.
• Ethnic backgrounds with higher carrier frequencies for specific sulfatase deficiency subtypes.

Symptoms

• Progressive neurological deterioration, including developmental delay or regression.
• Muscle weakness, hypotonia, or spasticity.
• Seizures or abnormal eye movements.
• Loss of motor skills or speech.
• Organ enlargement (e.g., hepatosplenomegaly in some subtypes).

Diagnosis

Diagnosis involves clinical evaluation of neurological symptoms, followed by biochemical testing to measure sulfatase enzyme activity in blood or tissue samples. Genetic testing may confirm mutations in specific sulfatase genes. Imaging studies (e.g., MRI) may reveal characteristic brain abnormalities.

Treatment Options

Treatment is primarily supportive and symptomatic, focusing on managing neurological symptoms (e.g., anticonvulsants for seizures) and addressing complications. Enzyme replacement therapy or substrate reduction therapy may be considered in specific subtypes, though availability varies. Multidisciplinary care involving neurologists, geneticists, and rehabilitation specialists is often required.

Prognosis and Follow-Up

Prognosis depends on the subtype and severity of neurological involvement, with progressive decline common in severe cases. Regular follow-up with neurologists and genetic counselors is essential to monitor disease progression, manage symptoms, and provide family support. Early intervention may help optimize quality of life.

Complications

• Progressive neurological damage, including cognitive impairment or motor dysfunction.
• Seizure disorders or movement abnormalities.
• Respiratory complications due to muscle weakness.
• Organ dysfunction (e.g., liver or spleen involvement in some subtypes).

Lifestyle & Prevention

• Genetic counseling for families with a history of sulfatase deficiency to discuss inheritance risks.
• Prenatal testing or carrier screening may be considered for at-risk pregnancies.
• Supportive care, including physical therapy and occupational therapy, to maintain function.

When to Seek Professional Help

Seek medical attention if symptoms of progressive neurological decline (e.g., developmental regression, seizures, or muscle weakness) are observed, especially in individuals with a family history of lysosomal storage disorders. Early diagnosis and intervention can improve outcomes.

Tips for Medical Coders

Document the specific subtype of sulfatase deficiency (if known) and any associated neurological or systemic manifestations. Ensure coding aligns with clinical documentation, as sulfatase deficiency is a rare disorder with variable presentations. Verify that the code E75.26 is used for sulfatase deficiency and not other sphingolipidosis subtypes.